Event Details
September 01, 2016
Description
GW announced that Epidiolex's second Phase III pivotal trial (GWPCARE3) in the treatment of Lennox-Gastaut syndrome was also successful.
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| ARM | organization | 125 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024905.jpg
This document is page 89 of a Cowen Collaborative Insights research report dated February 25, 2019. It provides a detailed analysis of Phase 3 clinical trials for the drug Epidiolex (produced by GW Pharma) for the treatment of Lennox-Gastaut syndrome (LGS), including trial designs, efficacy statistics regarding seizure reduction, and adverse event data. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was collected as part of a congressional investigation.
Related Events
Events with shared participants
Planned attack date by al Qaeda (per flier); actual deployment of Egyptian 2nd Army troops to el-Arish.
0012-08-01 • el-Arish, Sinai
AAN 2017 Presentation
2017-01-01 • Unknown (AAN Conference)
Launch of programme for the acquisition of 72 Typhoon aircraft and modernization of Saudi Armed Forces.
2007-01-01 • Saudi Arabia
32 million worth of digital currency ether stolen by hackers
2017-07-20 • Online
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event